Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System

Expanded reimbursement under the New Technology Add-on Payment program is expected to increase accessibility to a unique dual seizure and delirium monitoring platform. This development will significantly benefit patients, as well as healthcare providers, by enhancing access to innovative healthcare solutions. The increase in reimbursement stands to impact a large number of individuals seeking improved monitoring and care, further highlighting the potential positive outcomes of this program expansion.